Paricalcitol
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 777 publications
Cost-effectiveness analysis comparison of etelcalcetide, paricalcitol, and cinacalcet for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: August 17, 2026
Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular Analyses.
Journal: Cancer research communications
Published: June 30, 2026
Intravenous Paricalcitol Versus Calcitriol for Secondary Hyperparathyroidism in Maintenance Hemodialysis: A Six-Month Single-Center Retrospective Cohort Study.
Journal: Journal of clinical medicine
Published: June 09, 2026
Recurrent Calciphylaxis With Discordant Parathyroid Hormone Trajectory in a Patient With HIV-Associated End-Stage Renal Disease: A Case Report.
Journal: Cureus
Published: May 29, 2026
Serum 25(OH) vitamin D and SIRT1- VDR- miR-124 expression: A controlled interventional study in a vitamin D-deficient male rat model.
Journal: Experimental gerontology
Published: March 05, 2026
A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer.
Journal: The oncologist
Published: March 02, 2026
ProAgio, a Novel Integrin αvβ3 Targeted Cytotoxin, Suppresses Tumor Growth and Reprograms the PDAC Microenvironment.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
COL1A1 and SERPINE1 as Potential Therapeutic Targets in Diabetic Retinopathy: A Study Incorporating RNA Transcriptomics, Single-Cell RNA Sequencing, and Proteomics.
Journal: Human mutation
Published: February 05, 2026
Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis.
Journal: Clinical nephrology
Published: December 11, 2025
Last Updated: 09/26/2026